VAZCULEP Trademark

Trademark Overview

On Tuesday, July 17, 2012, a trademark application was filed for VAZCULEP with the United States Patent and Trademark Office. The USPTO has given the VAZCULEP trademark a serial number of 85679127. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, July 19, 2025. This trademark is owned by Éclat Pharmaceuticals, LLC. The VAZCULEP trademark is filed in the Pharmaceutical Products category with the following description:

Medication used to maintain blood pressure
vazculep

General Information

Serial Number85679127
Word MarkVAZCULEP
Filing DateTuesday, July 17, 2012
Status800 - REGISTERED AND RENEWED
Status DateSaturday, July 19, 2025
Registration Number4704141
Registration DateTuesday, March 17, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 25, 2012

Trademark Statements

Goods and ServicesMedication used to maintain blood pressure

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 24, 2012
Primary Code005
First Use Anywhere DateSaturday, November 1, 2014
First Use In Commerce DateSaturday, November 1, 2014

Trademark Owner History

Party NameEXELA STERILE MEDICINES LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressLENOIR, NC 28645
Party NameÉclat Pharmaceuticals, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressChesterfield, MO 63005
Party NameÉclat Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressChesterfield, MO 63005
Party NameÉclat Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressChesterfield, MO 63005

Trademark Events

Event DateEvent Description
Wednesday, December 5, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 20, 2012NEW APPLICATION ENTERED
Tuesday, July 24, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 9, 2012ASSIGNED TO EXAMINER
Tuesday, November 13, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 5, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 25, 2012PUBLISHED FOR OPPOSITION
Tuesday, December 25, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 19, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 28, 2013SOU TEAS EXTENSION RECEIVED
Tuesday, May 28, 2013SOU EXTENSION 1 FILED
Tuesday, June 25, 2013SOU EXTENSION 1 GRANTED
Tuesday, June 25, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 26, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 5, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 23, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 16, 2014USE AMENDMENT FILED
Tuesday, February 11, 2014SOU TEAS EXTENSION RECEIVED
Tuesday, February 11, 2014SOU EXTENSION 2 FILED
Thursday, February 20, 2014SOU EXTENSION 2 GRANTED
Friday, February 21, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 20, 2014SOU TEAS EXTENSION RECEIVED
Tuesday, May 20, 2014SOU EXTENSION 3 FILED
Thursday, May 22, 2014SOU EXTENSION 3 GRANTED
Tuesday, December 16, 2014TEAS STATEMENT OF USE RECEIVED
Saturday, January 10, 2015STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 3, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 6, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, February 7, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 17, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, March 17, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, July 15, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, March 3, 2021TEAS SECTION 8 & 15 RECEIVED
Wednesday, March 3, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 3, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 3, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 12, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, March 17, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Saturday, July 19, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, March 3, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 12, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, July 12, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, February 21, 2025TEAS SECTION 8 & 9 RECEIVED
Saturday, July 19, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, July 19, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, July 19, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Related Keywords

vazculep pressure blood maintain used medication